Catherine J. Wu

Molecular Biology · 2011–2020

A researcher in the Science corpus: 17 papers; trusts 5 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom Catherine J. Wu trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. N. Restifo
  2. Lloyd J. Old
  3. Robert Schreiber
  4. Steven L. Salzberg
  5. Ben Langmead

Who trusts Catherine J. Wu overall

  1. Nicholas McGranahan

Papers from Catherine J. Wu's perspective

Ordered by how strongly the researchers Catherine J. Wu trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome (Science)
  2. An immune-active tumor microenvironment favors clinical response to ipilimumab (Cancer Immunology and Immunotherapy)
  3. PD-1 blockade induces responses by inhibiting adaptive immune resistance (Nature)
  4. PD-1 blockade in tumors with mismatch repair deficiency. (Journal of Clinical Oncology)
  5. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. (Proceedings of the National Academy of Sciences of the United States of America)
  6. Novel cancer immunotherapy agents with survival benefit: recent successes and next steps (Nature Reviews. Cancer)
  7. Mining Exomic Sequencing Data to Identify Mutated Antigens Recognized by Adoptively Transferred Tumor-reactive T cells (Nature Medicine)
  8. Absolute quantification of somatic DNA alterations in human cancer (Nature Biotechnology)
  9. High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma (Nature Medicine)
  10. Neoantigens in cancer immunotherapy (Science)

Their papers